Oncology Ultrasound

While facilitating interdisciplinary colloaboration is a central objective with enterprise imaging platforms, this author says implementation of these platforms must ensure optimal patient privacy in sensitive cases involving abuse, assault and domestic violence.

In a recent letter to U.S. Rep. Rosa DeLauro (D-CT), the Food and Drug Administration (FDA) said a final rule on amendments to the Mammography Quality Standards Act (MQSA), including an oft-delayed national standard for breast density notification in mammography reporting, may be published in the next couple of months.

Catch up on the top radiology content of the past week.

Offering the benefits of real-time collaboration and integrated connectivity, the portable ultrasound device may be utilized in a variety of clinical settings ranging from cardiology to obstetrics and gynecology.

In light of recent shortages of iodinated contrast media, researchers from Australia suggest in a new publication that ultrasound and magnetic resonance imaging (MRI) can be viable first-line imaging options for a number of non-urgent presentations of the head and neck.

The ability of QT Imaging’s QTscan, a quantitative transmission ultrasound modality, to calculate the ratio of fibroglandular volume to total breast volume may facilitate assessment of ongoing breast cancer treatments or selective hormone receptor modulation therapies.

Catch up on the top radiology content of the past week.

Offering uniform high-resolution images through a combination of beamforming and enhanced image processing, the new ultrasound platform reportedly has an array of diagnostic features ranging from cardiovascular applications to breast lesion assessment.

In comparison to initial sonographer assessment of echocardiograms, cardiologists are over 10 percent less likely to change initial artificial intelligence (AI) assessment of left ventricular ejection fraction (LVEF), according to new research recently presented at the European Society of Cardiology Congress in Barcelona, Spain.

Researchers found the combination of magnetic resonance imaging (MRI) and contrast-enhanced mammography was nearly 22 percent more effective at detecting breast lesions than MRI-directed ultrasound.

Catch up on the top radiology content of the past week.

While the Ovarian-Adnexal Reporting and Data System ultrasound (O-RADS US) system provides a standardized and validated system for classification and risk stratification of ovarian and adnexal masses, a variety of clinical scenarios may prohibit or limit use of the system.

Catch up on the top radiology content of the past week.

A recently published prospective study comparing multiparametric magnetic resonance imaging (MRI) and micro-ultrasound found similar detection rates for prostate cancer.

Catch up on the top radiology content of the past week.

An updated machine learning model demonstrated a 23 percent improvement in accuracy and a 36.1 percent improvement in sensitivity over visual radiologist assessment of ultrasound images for differentiating malignant lymph nodes and benign COVID-19 vaccination-related changes to lymph nodes.

Catch up on the top radiology content of the past week.

While COVID-19 vaccine clinical trials noted that post-vaccine axillary lymphadenopathy lasted for one to 10 days, emerging breast ultrasound research found a mean resolution of 127 days after a first vaccine dose.

Check out top radiology content from the past week.

Based on findings from what may be the first longitudinal study of gallbladder polyps in patients with underlying liver disease, researchers suggested that size change thresholds for cholecystectomy may need to be reevaluated.

The portable ATUSA™ System reportedly provides 3D ultrasound visualization of the entire breast volume in two minutes.

A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

What is your diagnosis?

Distinguishing between classic and non-classic presentations of isolated adnexal lesions on pelvic ultrasound reportedly had a high specificity and sensitivity in diagnosing ovarian cancer in women at average risk.

In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.

Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.

The iBreastExam, a handheld device cleared by the FDA, reportedly enhances routine clinical breast examinations.

Will this artificial intelligence technology improve diagnostic accuracy and reduce false positive biopsy orders?

Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.